BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, December 26, 2025
Home » Authors » Catherine Hollingsworth

Articles by Catherine Hollingsworth

Pervasis, FDA Agree on Phase III as Partner Talks Advance

Feb. 2, 2010
By Catherine Hollingsworth

Gilead Earnings Rise on Atripla, Truvada Sales

Jan. 28, 2010
By Catherine Hollingsworth

Germany's Priaxon Getting up to $122M in Boehringer Cancer Deal

Jan. 27, 2010
By Catherine Hollingsworth

Keryx has Good Phase II Data for Perifosine in Colon Cancer

Jan. 26, 2010
By Catherine Hollingsworth

Achillion to Raise $19.7M to Bolster its Hepatitis Program

Jan. 25, 2010
By Catherine Hollingsworth

Elevation Pharma Hauls in $30M Series A to Fund COPD Studies

Jan. 22, 2010
By Catherine Hollingsworth

Lexicon Reports Positive Results from Phase II Diabetes Study

Jan. 21, 2010
By Catherine Hollingsworth

Germany's Priaxon Getting up to $122M in Boehringer Cancer Deal

Jan. 20, 2010
By Catherine Hollingsworth

NewCo News: JDP, with New CEO on Board, Goes for PC, Allergy Markets

Jan. 20, 2010
By Catherine Hollingsworth

BioInvent Plans to Raise $21M in Share Offering to Push Pipeline

Jan. 15, 2010
By Catherine Hollingsworth
Sweden's BioInvent International AB plans to raise SEK150 million (US$21M) by issuing 5.4 million new shares, money that could strengthen the company's position as it looks for new collaborations and opportunities to extend its pipeline. (BioWorld Today)
Read More
Previous 1 2 … 14 15 16 17 18 19 20 21 22 … 64 65 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 24, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 24, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing